Critical and clinical evaluation of ticarbodine as a canine anthelmintic.
D000722:Ancylostoma; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005069:Evaluation Studies as Topic; D005243:Feces; D005260:Female; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy* / Q000662:veterinary; D008297:Male; D009349:Nematode Infections / Q000188:drug therapy; D010270:Parasite Egg Count; D010880:Piperidines / Q000627:therapeutic use*; D013045:Species Specificity; D013440:Sulfides / Q000627:therapeutic use; D014052:Toluidines / Q000627:therapeutic use; D014114:Toxascaris; D014119:Toxocara; D014258:Trichuris
D000871:Anthelmintics; D010880:Piperidines; D013440:Sulfides; D014052:Toluidines